Fact Sheet: President Donald J. Trump Ensures American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve

Fact sheetProcurementPublished 25/08/13Open the original

Summary

President Trump orders the Strategic Active Pharmaceutical Ingredients Reserve filled: ASPR lists about 26 critical drugs and obtains a 6-month supply of their APIs, preferring domestic production. The fact sheet says only about 10% of APIs for U.S. prescription drugs are made domestically.

By industry

Healthcare & Drug Pricing1 trading day+1.4%p15 stocks5 trading days+5.5%p15 stocks20 trading days+4.8%p15 stocks
“fill the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR) with critical drug components”

Day by day after the announcement

Healthcare & Drug Pricing stocks and the S&P 500 after the announcement, cumulative %
Day	Healthcare & Drug Pricing stocks	S&P 500
25/08/12	0.0%	0.0%
25/08/13	+1.7%	+0.3%
25/08/14	+3.5%	+0.4%
25/08/15	+4.5%	+0.1%
25/08/18	+4.5%	+0.1%
25/08/19	+5.0%	−0.4%
25/08/20	+5.8%	−0.7%
25/08/21	+5.9%	−1.1%
25/08/22	+5.7%	+0.4%
25/08/25	+4.3%	+0.1%
25/08/26	+4.5%	+0.5%
25/08/27	+4.7%	+0.5%
25/08/28	+4.2%	+1.0%
25/08/29	+5.1%	+0.4%
25/09/02	+5.7%	−0.0%
25/09/03	+5.4%	+0.1%
25/09/04	+5.0%	+1.1%
25/09/05	+5.5%	+0.6%
25/09/08	+5.1%	+1.0%
25/09/09	+6.5%	+1.4%
25/09/10	+6.3%	+1.5%

Korean stocks in these industries

Samsung Biologics 207940
Celltrion 068270
SK Biopharmaceuticals 326030

Trades in these industries around the announcement

Members' and insiders' trades in the industries' stocks, 30 days before to 30 days after.

David A. RicksPresident, Chair, and CEO
BuyELI Lilly
Buy
ELI Lilly
LLY
$1.1M
1,632 sh
$1.1M
Filed 25/08/12
Traded 25/08/12
Lucas MontarceEVP & CFO
BuyELI Lilly
Buy
ELI Lilly
LLY
$494.6K
715 sh
$494.6K
Filed 25/08/15
Traded 25/08/15
Jacob Van NaardenEVP & Pres., Lilly Oncology
BuyELI Lilly
Buy
ELI Lilly
LLY
$647.4K
1,000 sh
$647.4K
Filed 25/08/13
Traded 25/08/13
Daniel SkovronskyEVP, CSO & Pres. LRL & LLY Imm
BuyELI Lilly
Buy
ELI Lilly
LLY
$634.4K
1,000 sh
$634.4K
Filed 25/08/12
Traded 25/08/12
J. Erik FyrwaldDirector
BuyELI Lilly
Buy
ELI Lilly
LLY
$564.8K
879 sh
$564.8K
Filed 25/08/12
Traded 25/08/12
Ralph AlvarezDirector
BuyELI Lilly
Buy
ELI Lilly
LLY
$500.5K
758 sh
$500.5K
Filed 25/08/14
Traded 25/08/13
J. Erik FyrwaldDirector
BuyELI Lilly
Buy
ELI Lilly
LLY
$440.4K
686 sh
$440.4K
Filed 25/08/12
Traded 25/08/12
Jamere JacksonDirector
BuyELI Lilly
Buy
ELI Lilly
LLY
$127.9K
200 sh
$127.9K
Filed 25/08/08
Traded 25/08/08
Gabrielle SulzbergerDirector
BuyELI Lilly
Buy
ELI Lilly
LLY
$75K
117 sh
$75K
Filed 25/08/12
Traded 25/08/12
Gail BoudreauxPresident and CEO
BuyElevance Health
Buy
Elevance Health
ELV
$1.5M
5,116 sh
$1.5M
Filed 25/07/18
Traded 25/07/18
Gail BoudreauxPresident and CEO
BuyElevance Health
Buy
Elevance Health
ELV
$667.7K
2,334 sh
$667.7K
Filed 25/07/18
Traded 25/07/18
Gail BoudreauxPresident and CEO
BuyElevance Health
Buy
Elevance Health
ELV
$302.4K
1,050 sh
$302.4K
Filed 25/07/18
Traded 25/07/18
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$82.8M
102,975 sh
$82.8M
Filed 25/07/25
Traded 25/07/24
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$51.1M
63,566 sh
$51.1M
Filed 25/07/25
Traded 25/07/24
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$37.7M
46,771 sh
$37.7M
Filed 25/07/25
Traded 25/07/24
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$29.2M
36,183 sh
$29.2M
Filed 25/07/25
Traded 25/07/24
Joaquin DuatoCEO and Chairman
SellJohnson & Johnson
Sell
Johnson & Johnson
JNJ
$22.5M
125,824 sh
$22.5M
Filed 25/08/25
Traded 25/08/22
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$17.9M
22,138 sh
$17.9M
Filed 25/07/25
Traded 25/07/24
Susan D. DeVoreDirector
BuyElevance Health
Buy
Elevance Health
ELV
$374.6K
1,200 sh
$374.6K
Filed 25/08/21
Traded 25/08/19
Lilly Endowment10% Owner
SellELI Lilly
Sell
ELI Lilly
LLY
$6.8M
8,367 sh
$6.8M
Filed 25/07/25
Traded 25/07/24